MedTrace Logo

Alzheimer's National Registry for Treatment and Diagnostics(ALZ-NET)

NCT06170268 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20000

Last updated 2023-12-14

No results posted yet for this study

Summary

The Alzheimer's Network for Treatment and Diagnostics (ALZ-NET) will collect longitudinal clinical and safety data for enrolled patients being evaluated for or treated with novel FDA-approved Alzheimer's disease (AD) therapies. ALZ-NET is a longitudinal registry with an expandable platform, designed to grow with scientific and medical advancements. As new treatments are approved and implemented in care, ALZ-NET will track the long-term health outcomes associated with their use in a real-world setting. ALZ-NET is a resource for evidence gathering, information sharing and education across clinical and research communities, encouraging innovative research and supporting opportunities to improve clinical care delivery. All participating physicians and site staff will complete comprehensive training to ensure adherence of data requirements and registry timelines.

Conditions

  • Alzheimer Disease

Interventions

OTHER

Routine Care Documentation

Routine Care Documentation

Sponsors & Collaborators

  • American College of Radiology

    collaborator OTHER

  • The Critical Path Institute

    collaborator UNKNOWN

  • Brown University

    collaborator OTHER

  • American Society of Neuroradiology

    collaborator UNKNOWN

  • Alzheimer's Disease and Related Disorders Association, Inc

    lead OTHER

Principal Investigators

  • Gil Rabinovici, MD · University of California, San Francisco

  • Maria C Carillo, PhD · Alzheimer's Association

  • Michael S Rafii, MD, PhD · University of Southern California

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-20
Primary Completion
2032-12-31
Completion
2032-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06170268 on ClinicalTrials.gov